The activin-follistatin system in the neonatal ovine uterus.
Uterine gland development or adenogenesis in the neonatal ovine uterus involves budding and tubulogenesis followed by coiling and branching morphogenesis of the glandular epithelium (GE) from the luminal epithelium (LE) between birth (Postnatal Day [PND] 0) and PND 56. Activins, which are members of the transforming growth factor beta superfamily, and follistatin, an inhibitor of activins, regulate epithelial branching morphogenesis in other organs. The objective of the present study was to determine effects of postnatal age on expression of follistatin, inhibin alpha subunit, betaA subunit, betaB subunit, activin receptor (ActR) type IA, ActRIB, and ActRII in the developing ovine uterus. Ewes were ovariohysterectomized on PND 0, 7, 14, 21, 28, 35, 42, 49, or 56. The uterus was analyzed by in situ hybridization and immunohistochemistry. Neither inhibin alpha subunit mRNA or protein was detected in the neonatal uterus. Expression of betaA and betaB subunits was detected predominantly in the endometrial LE and GE and myometrium between PND 0 and PND 56. In all uterine cell types, ActRIA, ActRIB, and ActRII were expressed, with the highest levels observed in the endometrial LE and GE and myometrium. Between PND 0 and PND 14, follistatin was detected in all uterine cell types. However, between PND 21 and PND 56, follistatin was only detected in the stroma and myometrium and not in the developing GE. Collectively, the present results indicate that components of the activin-follistatin system are expressed in the developing neonatal ovine uterus and are potential regulators of endometrial gland morphogenesis.
Hayashi
Kanako
K
Department of Animal Science, Texas A&M University, College Station, Texas 77843-2471, USA.
Carpenter
Karen D
KD
Gray
C Allison
CA
Spencer
Thomas E
TE
D029404:Activin Receptors / Q000235:genetics / Q000378:metabolism; D028341:Activins / Q000378:metabolism*; D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D002454:Cell Differentiation; D002455:Cell Division; D004717:Endometrium / Q000166:cytology / Q000254:growth & development* / Q000378:metabolism; D004848:Epithelium / Q000254:growth & development* / Q000378:metabolism; D005260:Female; D038681:Follistatin / Q000378:metabolism*; D018507:Gene Expression Regulation, Developmental; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D028322:Inhibin-beta Subunits / Q000235:genetics / Q000378:metabolism; D007265:Inhibins / Q000235:genetics / Q000378:metabolism; D009024:Morphogenesis / Q000502:physiology; D009215:Myometrium / Q000166:cytology / Q000254:growth & development / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D012756:Sheep / Q000502:physiology*
D038681:Follistatin; D012333:RNA, Messenger; C103008:inhibin beta A subunit; C094377:inhibin-alpha subunit; D028341:Activins; D007265:Inhibins; D028322:Inhibin-beta Subunits; D029404:Activin Receptors